The FSH Society and the FSHD Canada Foundation announce first joint effort to fund FSHD research using human induced pluripotent stem cell (hiPSC) technology that could lead to new insight […]
The FSH Society and the FSHD Canada Foundation Announce First Joint Effort
FSHD Connect conference slides are here!
Here are the slide decks from the 2014 FSHD Connect conference. We are still missing a few and are working to complete the collection. Alexandra Belayew: Several ways to go […]
aTyr Announces First FSHD Clinical Trial of Resolaris™
San Diego-based biotech company aTyr Pharma announced today its first clinical trial in FSHD patients of its investigational new drug Resolaris™. The Phase 1b/2 study is a double-blind, placebo-controlled, multiple ascending dose […]
Bone Health in FSHD–What do I need to know?
[…] health is a topic that until recently has not been discussed in the context of FSHD, but we are beginning to realize that it is a significant medical concern in […]
FSHD Connect conference agendas now available!
The program agendas for our FSHD Connect conferences are now available to download. Please click on the links provided below. We thank our generous sponsors for their support! FSHD Research […]